Elevated levels of plasma angiogenic factors are associated with human lymphatic filarial infections

American Journal of Tropical Medicine and Hygiene

Volumn 83, Issue 4, 2010, Pages 884-890

  Bennuru, Sasisekhar ^a   Maldarelli, Grace ^a   Kumaraswami, V ^b   Klion, Amy D ^a   Nutman, Thomas B ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; BASIC FIBROBLAST GROWTH FACTOR; DOXYCYCLINE; PLACENTAL GROWTH FACTOR; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D; ANGIOGENIC PROTEIN; ANGIOPOIETIN; ANTIFILARIAL AGENT; FIBROBLAST GROWTH FACTOR 2; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; LYMPHATIC FILARIASIS; LYMPHEDEMA; MAJOR CLINICAL STUDY; MANSONELLA PERSTANS; MIXED INFECTION; WUCHERERIA BANCROFTI; ADOLESCENT; ANIMAL; BLOOD; INDIA; MALI; METABOLISM; MIDDLE AGED; PARASITOLOGY;

FILARIA; WOLBACHIA; WUCHERERIA BANCROFTI;

ADOLESCENT; ADULT; AGED; ANGIOGENIC PROTEINS; ANGIOPOIETINS; ANIMALS; DOXYCYCLINE; ELEPHANTIASIS, FILARIAL; FIBROBLAST GROWTH FACTOR 2; FILARICIDES; HUMANS; INDIA; MALI; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTORS; WUCHERERIA BANCROFTI; YOUNG ADULT;

EID: 79958056972     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.10-0039     Document Type: Article

References (51)

1. Alitalo K, Tammela T, Petrova TV, 2005. Lymphangiogenesis in development and human disease. Nature 438: 946-953. (Pubitemid 43093960)
2. Klei TR, Enright FM, Blanchard DP, Uhl SA, 1981. Specific hyporesponsive granulomatous tissue reactions in Brugia pahangi-infected birds. Acta Trop 38: 267-276. (Pubitemid 12238548)
3. Nutman TB, Kumaraswami V, Pao L, Narayanan PR, Ottesen EA, 1987. An analysis of in vitro B cell immune responsiveness in human lymphatic filariasis. J Immunol 138: 3954-3959. (Pubitemid 17078279)
4. Ottesen EA, 1980. Immunopathology of lymphatic filariasis in man. Springer Semin Immunopathol 2: 373-385. (Pubitemid 10089632)
5. Piessens WF, McGreevy PB, Piessens PW, McGreevy M, Koiman I, Saroso JS, Dennis DT, 1980. Immune responses in human infections with Brugia malayi: specific cellular unresponsiveness to filarial antigens. J Clin Invest 65: 172-179. (Pubitemid 10214344)
6. Ristimaki A, Narko K, Enholm B, Joukov V, Alitalo K, 1998. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 273: 8413-8418. (Pubitemid 28168903)
7. Debrah AY, Mand S, Specht S, Marfo-Debrekyei Y, Batsa L, Pfarr K, Larbi J, Lawson B, Taylor M, Adjei O, Hoerauf A, 2006. Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathog 2: e92.
8. Bennuru S, Nutman TB, 2009. Lymphangiogenesis and lymphatic remodeling induced by filarial parasites: implications for pathogenesis . PLoS Pathog 5: e1000688.
9. Gopinath R, Hanna LE, Kumaraswami V, Perumal V, Kavitha V, Vijayasekaran V, Nutman TB, 2000. Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis. Infect Immun 68: 93-99. (Pubitemid 30016682)
10. Coulibaly YI, Dembele B, Diallo AA, Lipner EM, Doumbia SS, Coulibaly SY, Konate S, Diallo DA, Yalcouye D, Kubofcik J, Doumbo OK, Traore AK, Keita AD, Fay MP, Traore SF, Nutman TB, Klion AD, 2009. A randomized trial of doxycycline for Mansonella perstans infection. N Engl J Med 361: 1448-1458.
11. Augustin HG, Koh GY, Thurston G, Alitalo K, 2009. Control of vascular morphogenesis and homeostasis through the angiopoietin-tie system. Nat Rev Mol Cell Biol 10: 165-177.
12. Lovegrove FE, Tangpukdee N, Opoka RO, Lafferty EI, Rajwans N, Hawkes M, Krudsood S, Looareesuwan S, John CC, Liles WC, Kain KC, 2009. Serum angiopoietin-1 and-2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS ONE 4: e4912.
13. Shantha Kumara HM, Hoffman A, Kim IY, Feingold D, Dujovny N, Kalady M, Luchtefeld M, Whelan RL, 2009. Colorectal resection, both open and laparoscopic-assisted, in patients with benign indications is associated with proangiogenic changes in plasma angiopoietin 1 and 2 levels. Surg Endosc 23: 409-415.
14. Debrah AY, Mand S, Toliat MR, Marfo-Debrekyei Y, Batsa L, Nurnberg P, Lawson B, Adjei O, Hoerauf A, Pfarr K, 2007. Plasma vascular endothelial growth Factor-A (VEGF-A) and VEGF-A gene polymorphism are associated with hydrocele development in lymphatic filariasis. Am J Trop Med Hyg 77: 601-608. (Pubitemid 351844277)
15. Esterre P, Plichart C, Huin-Blondey MO, Nguyen LN, 2005. Soluble cellular adhesion molecules, selectins, VEGF and endothelin-1 in patients with Wuchereria bancrofti infection and association with clinical status. Parasite Immunol 27: 9-16. (Pubitemid 40524988)
16. Karpanen T, Alitalo K, 2008. Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol 3: 367-397. (Pubitemid 351488286)
17. Bruno E, Cooper RJ, Wilson EL, Gabrilove JL, Hoffman R, 1993. Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells. Blood 82: 430-435. (Pubitemid 23206105)
18. Wilson EL, Rifkin DB, Kelly F, Hannocks MJ, Gabrilove JL, 1991. Basic fibroblast growth factor stimulates myelopoiesis in longterm human bone marrow cultures. Blood 77: 954-960.
19. Mandriota SJ, Pepper MS, 1997. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J Cell Sci 110: 2293-2302. (Pubitemid 27448373)
20. Hasebe T, Imoto S, Ogura T, Mukai K, 1997. Significance of basic fibroblast growth factor and fibroblast growth factor receptor protein expression in the formation of fibrotic focus in invasive ductal carcinoma of the breast. Jpn J Cancer Res 88: 877-885. (Pubitemid 27475090)
21. Ohshima K, Sugihara M, Suzumiya J, Haraoka S, Kanda M, Shimazaki K, Katoh K, Kumagawa M, Kikuchi M, 1999. Basic fibroblast growth factor and fibrosis in Hodgkin's disease. Pathol Res Pract 195: 149-155. (Pubitemid 29142212)
22. Ebos JM, Lee CR, Bogdanovic E, Alami J, Van Slyke P, Francia G, Xu P, Mutsaers AJ, Dumont DJ, Kerbel RS, 2008. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth. Cancer Res 68: 521-529. (Pubitemid 351380080)
23. Herold-Mende C, Steiner HH, Andl T, Riede D, Buttler A, Reisser C, Fusenig NE, Mueller MM, 1999. Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells. Lab Invest 79: 1573-1582. (Pubitemid 30013922)
24. Pallares J, Rojo F, Iriarte J, Morote J, Armadans LI, de Torres I, 2006. Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues. Histol Histopathol 21: 857-865. (Pubitemid 44082728)
25. Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E, 2006. Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients. Melanoma Res 16: 405-411. (Pubitemid 44511220)
26. Hu Q, Dey AL, Yang Y, Shen Y, Jilani IB, Estey EH, Kantarjian HM, Giles FJ, Albitar M, 2004. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes. Cancer 100: 1884-1891. (Pubitemid 38529566)
27. Faderl S, Do KA, Johnson MM, Keating M, O'Brien S, Jilani I, Ferrajoli A, Ravandi-Kashani F, Aguilar C, Dey A, Thomas DA, Giles FJ, Kantarjian HM, Albitar M, 2005. Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia. Blood 106: 4303-4307. (Pubitemid 41775940)
28. Srikiatkhachorn A, Ajariyakhajorn C, Endy TP, Kalayanarooj S, Libraty DH, Green S, Ennis FA, Rothman AL, 2007. Virus induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic fever. J Virol 81: 1592-1600. (Pubitemid 46214434)
29. Tseng JJ, Chou MM, Hsieh YT, Wen MC, Ho ES, Hsu SL, 2006. Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accreta. Placenta 27: 70-78. (Pubitemid 41662882)
30. Deprimo SE, Bello CL, Smeraglia J, Baum CM, Spinella D, Rini BI, Michaelson MD, Motzer RJ, 2007. Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins. J Transl Med 5: 32.
31. Cohen EE, Rosen LS, Vokes EE, Kies MS, Forastiere AA, Worden FP, Kane MA, Sherman E, Kim S, Bycott P, Tortorici M, Shalinsky DR, Liau KF, Cohen RB, 2008. Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study. J Clin Oncol 26: 4708-4713.
32. Strumberg D, Schultheis B, Adamietz IA, Christensen O, Buechert M, Kraetzschmar J, Rajagopalan P, Ludwig M, Frost A, Steinbild S, Scheulen ME, Mross K, 2008. Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours. Br J Cancer 99: 1579-1585.
33. Kendall RL, Thomas KA, 1993. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 90: 10705-10709. (Pubitemid 23347111)
34. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM, 1999. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286: 2511-2514.
35. Papapetropoulos A, Garcia-Cardena G, Dengler TJ, Maisonpierre PC, Yancopoulos GD, Sessa WC, 1999. Direct actions of angiopoietin- 1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab Invest 79: 213-223. (Pubitemid 29110651)
36. Pizurki L, Zhou Z, Glynos K, Roussos C, Papapetropoulos A, 2003. Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production. Br J Pharmacol 139: 329-336. (Pubitemid 36760365)
37. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ, 1999. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284: 1994-1998. (Pubitemid 29309448)
38. Fainaru O, Adini I, Benny O, Bazinet L, Pravda E, D'Amato R, Folkman J, 2008. Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability. FASEB J 22: 3728-3735.
39. Eberhard ML, Hightower AW, Addiss DG, Lammie PJ, 1997. Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin. Am J Trop Med Hyg 57: 483-486. (Pubitemid 27439123)
40. Ismail MM, Jayakody RL, Weil GJ, Nirmalan N, Jayasinghe KS, Abeyewickrema W, Rezvi Sheriff MH, Rajaratnam HN, Amarasekera N, de Silva DC, Michalski ML, Dissanaike AS, 1998. Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. Trans R Soc Trop Med Hyg 92: 94-97. (Pubitemid 28073744)
41. Nicolas L, Plichart C, Nguyen LN, Moulia-Pelat JP, 1997. Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia. J Infect Dis 175: 489-492. (Pubitemid 27052266)
42. Weil GJ, Ramzy RM, El Setouhy M, Kandil AM, Ahmed ES, Faris R, 1999. A longitudinal study of Bancroftian filariasis in the Nile Delta of Egypt: baseline data and one-year follow-up. Am J Trop Med Hyg 61: 53-58. (Pubitemid 29344988)
43. Weil GJ, Sethumadhavan KV, Santhanam S, Jain DC, Ghosh TK, 1988. Persistence of parasite antigenemia following diethylcarbamazine therapy of bancroftian filariasis. Am J Trop Med Hyg 38: 589-595.
44. Dreyer G, Addiss D, Williamson J, Noroes J, 2006. Efficacy of coadministered diethylcarbamazine and albendazole against adult Wuchereria bancrofti. Trans R Soc Trop Med Hyg 100: 1118-1125. (Pubitemid 44478725)
45. Hussein O, El Setouhy M, Ahmed ES, Kandil AM, Ramzy RM, Helmy H, Weil GJ, 2004. Duplex Doppler sonographic assessment of the effects of diethylcarbamazine and albendazole therapy on adult filarial worms and adjacent host tissues in Bancroftian filariasis. Am J Trop Med Hyg 71: 471-477. (Pubitemid 39458341)
46. Noroes J, Dreyer G, Santos A, Mendes VG, Medeiros Z, Addiss D, 1997. Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo. Trans R Soc Trop Med Hyg 91: 78-81. (Pubitemid 27095509)
47. Ottesen EA, Duke BO, Karam M, Behbehani K, 1997. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 75: 491-503. (Pubitemid 28099975)
48. Debrah AY, Mand S, Marfo-Debrekyei Y, Batsa L, Pfarr K, Buttner M, Adjei O, Buttner D, Hoerauf A, 2007. Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti. Trop Med Int Health 12: 1433-1441. (Pubitemid 350212708)
49. Bennuru S, Semnani R, Meng Z, Ribeiro JM, Veenstra TD, Nutman TB, 2009. Brugia malayi excreted/secreted proteins at the host/ parasite interface: stage-and gender-specific proteomic profiling. PLoS Negl Trop Dis 3: e410.
50. Hewitson JP, Harcus YM, Curwen RS, Dowle AA, Atmadja AK, Ashton PD, Wilson A, Maizels RM, 2008. The secretome of the filarial parasite, Brugia malayi: proteomic profile of adult excretory-secretory products. Mol Biochem Parasitol 160: 8-21. (Pubitemid 351694354)
51. Moreno Y, Geary TG, 2008. Stage-and gender-specific proteomic analysis of Brugia malayi excretory-secretory products. PLoS Negl Trop Dis 2: e326.